Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

March 7, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Eatable antibody factories to combat deadly gut infections!

CHOCOLATE & GREASY FOOD - MORE ACNE?

NIRRH Associate Jobs Recruitment | Online Applications Invited

Eatable antibody factories to combat deadly gut infections!
  • BiotechToday
  • World

Eatable antibody factories to combat deadly gut infections!

bioxone October 31, 2020October 31, 2020

Jayateerth S. Bhavikatti, CSIR-National Chemical Laboratory, Pune.

Clostridioides difficile (C. diff) is a causative agent for diarrhoea and colitis (colon inflammation) and its infection occurs usually during or soon after the administration of antibiotics. This happens as a result of wiping out the gut microbiome. In the US, nearly 30,000 people die annually from C. diff infection. Two major toxins of C. diff are TcdA and TcdB. One way to combat C. diff is through monoclonal antibodies against both these toxins. The procedure for producing monoclonal antibodies is quite tough. What if we had a better and a feasible alternative to fight C. diff infection?

A study lead by Hanping Feng, a microbiologist at the University of Maryland School of Dentistry has come up with a very feasible, easy and an inexpensive way to answer this puzzle. They have used a genetically modified strain of the yeast Saccharomyces boulardii, to be taken as a probiotic. The S. boulardii produces antibodies against the two toxins of C. diff in our gut. The results are very promising in mice model. So it is like eating the yeast that produces required antibodies against C. diff. Feng also says that the clinical trials would begin in about the next three months. Although the challenge is, getting approval from the US-FDA for administering genetically modified yeast, which is the first of its kind. Let us hope for the best.

Also read: WILL COVID-19 VACCINE WORK?

References:

  1. Di Bella S, Ascenzi P, Siarakas S, Petrosillo N, di Masi A. Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects. Toxins (Basel). 2016 May 3;8(5):134. https://dx.doi.org/10.3390/toxins8050134. PMID: 27153087; PMCID: PMC4885049.
  2. https://www.cdc.gov/cdiff/index.html
  3. https://www.sciencemag.org/news/2020/10/antibody-producing-yeast-vanquishes-deadly-gut-infection-mice
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged C. diff colitis gut infection diarrhoea gut microbiome S. boulardii

2 thoughts on “Eatable antibody factories to combat deadly gut infections!”

  1. Pingback: Covid updates- Quantification of antibody through plasmonic substrates for SARS-CoV-2 Detection - BioXone
  2. Pingback: Barriers to developing clinical trials in Lewy body dementia - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Job and Internship
  • Signaling Pathway

NIRRH Associate Jobs Recruitment | Online Applications Invited

bioxone October 31, 2020

-Shristi Sharma, Team bioXone NIRRH Associate Jobs Recruitment – Online Applications Invited. NIRRH recruitment for Natural Sciences/ Molecular Biology candidates. NIRRH National Institute for Research in Reproductive Health latest job details, walk-in details, check out all of the information on the same below: NIRRH Job Details Designation: Project Associate-II Vacancies: 01 Project Title: “Omics of […]

Related Post

  • BiotechToday
  • World

RoseTTAFold: A software to predict protein structures using deep learning

BioTech Today July 21, 2021July 21, 2021

Varuni Ankolekar, Quartesian Lately, Artificial Intelligence has facilitated the discovery of much seamless software which has reduced the manual and cumbersome work. This has also helped in the field of Biochemistry and Structural biology. Now, the research team from the Institute for Protein Design at the University of Washington School of Medicine, Seattle has revealed […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Discovery of a better gene-editing tool?

bioxone October 23, 2020October 23, 2020

Shrayana Ghosh, Amity University Kolkata According to a new study by UC San Francisco scientists, gene editing for the generation of different treatments and the study of disease and normal function in humans and other organisms may develop more rapidly with a new tool for cutting larger pieces of DNA out of the genome of […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Treatment of Lymphoma in Dogs- Fully granted by FDA for the first time

bioxone July 29, 2021July 28, 2021

Nimrit Palan, Mumbai university One of the most prevalent types of cancer in dogs is lymphoma. It is made up of immune system cells called lymphocytes that circulate through the bloodstream. As a result, lymphoma is often seen as a systemic disease that requires systemic treatment. Dogs with lymphoma have a life expectancy of 1-2 […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy